Hints and tips:
Related Special Reports
...— though he adds that “the field is moving very fast”....
...New livers, hearts, kidneys: the idea of one day being able to 3D print replacement human organs has been a dream for scientists working in the field of regenerative medicine....
...Abbott Laboratories, the US pharmaceutical and healthcare company, has been preparing a takeover bid for St Jude Medical that was set to value the medical device maker at $25bn, people familiar with the...
...A study this spring by Abbott Laboratories of the US suggested that Indian generic companies’ copies of Kaletra, Abbott’s antiretroviral drug, were not absorbed in the same way in the body, raising questions...
...s case, LabCorp v Metabolite Laboratories, involves a patented method of correlating blood homocysteine levels with vitamin deficiencies, relating to heart attacks....
...Hoechst is now part of Sanofi Aventis, Knoll was bought by Abbott Laboratories of the US and Gödecke by Pfizer, the world’s largest pharmaceutical group (itself founded in New York by German emigré entrepreneurs...
...The birth of the field came in 1975 when César Milstein and Georges Köhler at the Laboratory of Molecular Biology in Cambridge, in the UK, discovered a way to produce unlimited copies of the same specific...
...Galway boasts three of the top four companies in this field, with Abbott the latest arrival, inheriting a stent plant as part of its 1995 takeover of Bio-Compatibles, a UK company....
International Edition